These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5980160)

  • 21. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faulty prescription--an avoidable cause of multidrug resistance tuberculosis.
    Jain RF
    J Indian Med Assoc; 1996 Oct; 94(10):385-8. PubMed ID: 9141879
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV and tuberculosis.
    Sharma SK; Ahluwalia G
    Indian J Chest Dis Allied Sci; 2000; 42(2):77-81. PubMed ID: 10916271
    [No Abstract]   [Full Text] [Related]  

  • 25. [Concepts and methods of treatment of pulmonary and extra-pulmonary tuberculosis].
    Fortic B
    Plucne Bolesti; 1984; 36(1-2):103-14. PubMed ID: 6334860
    [No Abstract]   [Full Text] [Related]  

  • 26. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
    Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems of tuberculosis in developing countries.
    Pamra SP
    Clin Chest Med; 1980 May; 1(2):265-71. PubMed ID: 7028375
    [No Abstract]   [Full Text] [Related]  

  • 28. A new epidemic.
    Mukherjee B
    J Indian Med Assoc; 1997 Apr; 95(4):119. PubMed ID: 9357279
    [No Abstract]   [Full Text] [Related]  

  • 29. Private pharmacies in tuberculosis control--a neglected link.
    Rajeswari R; Balasubramanian R; Bose MS; Sekar L; Rahman F
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):171-3. PubMed ID: 11931419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis.
    Katiyar SK; Sampath A; Bihari S; Mamtani M; Kulkarni H
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1146-52. PubMed ID: 18812044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Student recruitment for TB control.
    Davies PD; Williams CS
    Int J Tuberc Lung Dis; 1998 May; 2(5):438-9. PubMed ID: 9613644
    [No Abstract]   [Full Text] [Related]  

  • 32. [Complex treatment of destructive pulmonary tuberculosis].
    Shul'ga IA; Znosenko VA; Sukhorukova IS; Davydova GN; Surovtseva EIa; Shlapakova MA; Pelipas IG
    Probl Tuberk Bolezn Legk; 2003; (7):29-31. PubMed ID: 12939873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India.
    Thomas A; Gopi PG; Santha T; Chandrasekaran V; Subramani R; Selvakumar N; Eusuff SI; Sadacharam K; Narayanan PR
    Int J Tuberc Lung Dis; 2005 May; 9(5):556-61. PubMed ID: 15875929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi drug resistant tuberculosis.
    Khilnani GC; Sharma SK; Pande JN
    Indian J Chest Dis Allied Sci; 1994; 36(3):137-45. PubMed ID: 7737701
    [No Abstract]   [Full Text] [Related]  

  • 35. Tuberculosis and minimal change nephrotic syndrome in Lucknow, India.
    Rathi AK; Kapoor AK
    Trop Geogr Med; 1980 Sep; 32(3):227-30. PubMed ID: 7210157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India.
    Gopi PG; Vasantha M; Muniyandi M; Chandrasekaran V; Balasubramanian R; Narayanan PR
    Indian J Tuberc; 2007 Apr; 54(2):66-70. PubMed ID: 17575677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of haematological manifestations in patients with tuberculosis.
    Singh KJ; Ahluwalia G; Sharma SK; Saxena R; Chaudhary VP; Anant M
    J Assoc Physicians India; 2001 Aug; 49():788, 790-4. PubMed ID: 11837465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problem of drug default and role of 'motivation'.
    Seetha MA; Aneja KS
    Indian J Public Health; 1982; 26(4):234-43. PubMed ID: 7187661
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid decline in prevalence of pulmonary tuberculosis after DOTS implementation in a rural area of South India.
    Subramani R; Radhakrishna S; Frieden TR; Kolappan C; Gopi PG; Santha T; Wares F; Selvakumar N; Narayanan PR
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):916-20. PubMed ID: 18647451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc and copper in Indian patients of tuberculosis: impact on antitubercular therapy.
    Mohan G; Kulshreshtha S; Sharma P
    Biol Trace Elem Res; 2006; 111(1-3):63-9. PubMed ID: 16943598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.